Work

Phase I open-label, dose-escalation study of ANA773 tosylate, an oral prodrug of a toll-like receptor-7 agonist, in patients with advanced solid tumors.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.2524

Authors: G. A. Daniels, W. E. Carson, A. C. Mita, K. L. Kendra, M. H. Rahimy, D. W. Inman, J. R. Appleman, J. L. Freddo, D. G. McNeel

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2562019533

Cites:

Cited by: 4

Related to: 10